← SynDRA
VU-0155069
SynDRA canonical compound SYN0079818 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PLD1 |
|---|
| Mechanism of action | phospholipase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PLD1 INHIBITOR
- PLD2 INHIBITOR
- phospholipase inhibitor
Cross-references
Synonyms
- CAY10593
- CAY10593 (VU0155069)
- CHEMBL492572
- COMPOUND 69 [PMID: 19136975]
- VU0155069
- VU69
- MFCD23160355
- compound 69 [PMID: 19136975]
- C26H27ClN4O2
- GTPL8782
- SCHEMBL4540618
- GLXC-04483
- BDBM50258182
- AKOS032961459
- EBC-518446
- NCGC00370881-01
- AC-36223
- HY-108612
- CS-0029316
- E74843
- F544995
- BRD-K48535733-003-01-2
Look up VU-0155069 in the interactive SynDRA portal →